(1) Except as described in SB 450 (2023), a prescription must be labeled with the following information:
- (a) Name of patient;
- (b) Name of prescriber;
- (c) Name, address, and phone number of the clinic;
- (d) Date of dispensing;
- (e) Name and strength of the drug. If the drug does not have a brand name, then the generic name of the drug and the drug manufacturer must be stated;
- (f) Quantity dispensed;
- (g) Directions for use;
- (h) Cautionary statements, if any, as required by law; and
- (i) An expiration date after which the patient should not use the drug or medicine. Expiration dates on prescriptions must be the same as that on the original container or one year from the date the drug was originally dispensed and placed in the new container, whichever date is earlier. Any drug expiring before the expected length of time for course of therapy must not be dispensed.
- (j) Any dispensed prescription medication, other than those in unit dose or unit of use packaging, must be labeled with its physical description, including any identification code that may appear on tablets and capsules.
- (2) Not withstanding any other requirements in this rule, when a drug is dispensed in the practice of an Expedited Partner Therapy treatment protocol, as described in OAR 855-043-0004, the name of the patient may be omitted.
Statutory/Other Authority
ORS 689.205
Statutes/Other Implemented
ORS 689.155, ORS 689.305 & 2023 SB 450
History
BP 27-2023, amend filed 10/16/2023, effective 10/17/2023
BP 40-2021, amend filed 12/16/2021, effective 01/01/2022
BP 4-2017, adopt filed 11/30/2017, effective 12/01/2017